Biological properties of interferon-α produced ex vivo by whole blood of patients infected by human immunodeficiency virus-1

Scandinavian Journal of Immunology

Volumn 49, Issue 6, 1999, Pages 660-666

  Chehadeh, W ^a   Hober, Didier ^a,f   Chieux, V ^a   Alm, G ^b   Harvey, J ^c   Lion, G ^d   Mouton, Y ^e   Wattre P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UPPSALA UNIVERSITY   (Sweden)

^c NOVARTIS PHARMA AG   (Switzerland)

^d CENTRE HOSPITALIER DE VALENCIENNES   (France)

^e CENTRE HOSPITALIER DE TOURCOING   (France)

^f CHU Rouen BG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOPLASM PROTEIN;

AMNION CELL; ARTICLE; BLOOD CULTURE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; PRIORITY JOURNAL; SENDAI VIRUS; VESICULAR STOMATITIS VIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CYTOPATHOGENIC EFFECT, VIRAL; GTP-BINDING PROTEINS; HIV-1; HUMANS; INTERFERON-ALPHA; PROTEIN BIOSYNTHESIS; PROTEINS;

EID: 0032970504     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00552.x     Document Type: Article

References (33)

1. 1 Joklick WK. Interferons. In: Field NB, Knipe DM, Hawley PM, et al. eds. Virology. New York: Raven Press, 1990:383-410.
2. 2 Manetti R, Annunziato F, Tomasevic L et al. Polyinosinic acid: polycytidic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon α and interleukin-12. Eur J Immunol 1995;25:2656-60.
3. 3 Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. The role of interferons in the control of HIV replication in macrophages. Clin Immunol Immunopathol 1990;54:200-19.
4. 4 Saksela E, Virtanen I, Hovi T, Secher DS, Cantell K. Monocyte is the main producer of human alpha interferons following Sendai virus induction. Prog Med Virol 1984;30:78-86.
5. 5 Feldman S, Milone C, Klosser P, Fitzgerald-Bocarsly P. Functional deficiencies in two distinct interferon α-inducing cell populations in peripheral blood mononuclear cells from human immunodeficiency virus seropositive patients. J Leukocyte Biol 1995;57:214-20.
6. 6 Lopez C, Fitzgerald PA, Siegal FP. Severe acquired immune deficiency syndrome in male homosexuals. Diminished capacity to make interferon-alpha in vitro associated with severe opportunistic infections. J Infect Dis 1983;148:962-6.
7. 7 Uno K, Nakano K, Maruo N et al. Determination of interferon α-producing capacity in whole blood cultures from patients with various diseases and from healthy persons. J Interferon Cytokine Res 1996;16:911-8.
8. + patients as markers for monitoring of the AIDS progression. Arch Immunol Ther Exp 1994;42:439-45.
9. 9 Francis ML, Meltzer MS, Gendelman HE. Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS Res Hum Retrovirus 1992;8:199-207.
10. 10 Sen GC, Lengyel P. The interferon system. A bird's eye view of its biochemistry. J Biol Chem 1992;267:5017-20.
11. 11 Pavlovic J, Zurcher T, Haller O, Staeheli P. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol 1990;64:3370-5.
12. 12 Towbin H, Schmitz A, Jakschies D, von Wussow P, Horisberger M. A whole blood immunoassay for the interferon-inducible human Mx protein. J Interferon Res 1992;12:67-74.
13. 13 Ronni T, Melen K, Malygin A, Julkunen I. Control of IFN-inducible MxA gene expression in human cells. J Immunol 1993;150:1715-26.
14. 14 von Wussow P, Jakschies D, Block B et al. The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. AIDS 1990;4:119-24.
15. 15 Lairmoire M, Butera S, Callahan G, DeMartini J. Spontaneous interferon production by pulmonary leukocytes is associated with lentivirus-induced lymphoid interstitial pneumonia. J Immunol 1988;140:779-85.
16. 16 Gendelman H, Baca L, Kubrak C et al. Induction of IFNα in peripheral blood mononuclear cells by HIV-1 infected monocyte. Restricted antiviral activity of the HIV-induced IFN. J Immunol 1992;148:422-9.
17. 17 Garein D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA. Generation of a novel copy-back non-defective interfering virus. EMBO 1995;14:6087-94.
18. 18 Cederblad B, Blomberg S, Vallin H, Perers A, Alm G, Rönnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon α producing cells. J Autoimmun 1998;11:465-70.
19. 19 Lebon P, Commoy-Chevalier MJ, Robert-Galliot B, Morin A, Chany C. Production d'interferon humain de type 1 par des lymphocytes au contact de cellules infectées par le virus herpès et fixées par le glutaraldehyde. C R Seances Acad Sci D 1980;290:37-40.
20. 20 Chieux V, Hober D, Harvey J et al. The MxA protein levels in whole blood lysates of patients with various viral infections. J Virol Meth 1998;70:183-91.
21. 21 Cantell K, Pirhonen J. IFNγ enhances production of IFNα in human macrophages but not in monocytes. J Interferon Cytokine Res 1996;16:461-3.
22. 22 Horisberger M, Hochkeppel H. IFNα induced human 78 KD protein: purification and homologies with the mouse Mx protein, production of monoclonal antibodies, and potentiation effect of IFNγ. J Interferon Res 1987;7:331-43.
23. 23 Swindells S, Baldwin T, Kelly C et al. Regulation and characterzation of the interferon-α present in patients with advanced human immunodeficiency virus type 1 disease. J Interferon Cytokine Res 1996;16:127-37.
24. 24 Fitzgerald-Bocarsly P. Human natural interferon α producing cells. Pharmac Ther 1993;60:39-62.
25. 25 Ambrus JL, Ambrus LJ Jr, Chadha S et al. Mechanism(s) of interferon inhibitory activity in blood from patients with AIDS and patients with lupus erythematosus with vasculitis. Res Commun Mol Pathol Pharmacol 1997;96:255-65.
26. 26 Hua J, Liao M, Rashidbaigi A. Cytokines induced by Sendaï virus in human peripheral blood leukocytes. J Leukocyte Biol 1996;60:125-8.
27. 27 Sareneva T, Matikainen S, Kurimoto M, Julkunen I. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol 1998;160:6032-8.
28. 28 Ralph S, Wines B, Payne M et al. Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phophorylation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors. J Immunol 1995;154:2248-56.
29. 29 Baca L, Genis P, Kalvakolanu D et al. Regulation of interferon a-inducible cellular genes in human immunodeficiency virus-infected monocytes. J Leukocyte Biol 1994;55:299-309.
30. 30 Díaz MO, Bohlander S, Allen G. Nomenclature of the human interferon genes. J Interferon Res 1993;13:61-2.
31. 31 Pitha PM, Wei-Chun A. Induction of interferon alpha genes expression. Semin Virol 1995;6:151-9.
32. 32 Streuli M, Hall A, Boll W, Stewart WE, Nagata S, Weissmann C. Target cell specificity of two species of human interferon-α produced in Escherichia coli and hybrid molecules derived from them. Proc Nat Acad Sci USA 1981;78:2848-52.
33. 33 Ortaldo JR, Herberman RB, Harvey C et al. A species of human α interferon that lacks the ability to boost human natural killer activity. Proc Nat Acad Sci USA 1981;81:4926-29.